De Novo Variants in PPFIA2 in Individuals With Neurodevelopmental Disorders
American Journal of Medical Genetics Part A · 2026
DOI: 10.1002/ajmg.a.64255 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2026. Verfasst von Theresa Brunet und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Genetics, Klinikum Rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, Germany. Hauptthemen laut MEDLINE: Adaptor Proteins, Signal Transducing, Genetic Predisposition to Disease, Neurodevelopmental Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, European Joint Programme on Rare Diseases, German Federal Ministry of Education and Research.
Abstract (Originalsprache)
Liprin‐α2, encoded by PPFIA2 , belongs to the family of Liprin‐α proteins which constitute major synaptic scaffolds participating in the assembly and maturation of synapses. Heterozygous de novo variants in PPFIA2 were identified by exome or genome sequencing in two unrelated individuals with a neurodevelopmental disorder. The hypothesis of PPFIA2 as a novel candidate gene for a neurodevelopmental disorder is supported by the gnomAD gene constraint metrics and further strengthened by our identification of seven additional individuals in large cohort studies carrying rare de novo variants and presenting with overlapping phenotype. In summary, we provide evidence for the second gene‐disease association of a Liprin‐α protein beyond PPFIA3 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Human Genetics, Klinikum Rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, Germany.
- Bavarian Genomes Network for Rare Disorders, Munich, Germany.
- Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.
- Department of Paediatric Neurology, Thomayer University Hospital, Prague, Czech Republic.
- Department of Pediatric Neurology, Developmental Medicine and Social Pediatrics, Dr. von Hauner's Children's Hospital, University of Munich, Munich, Germany.
- Center for Research, Development, and Advanced Studies in Sardinia (CRS4), NGS Bioinformatics Loc. Pixinamanna, Pula, Italy.
ORCID-Profile: Theresa Brunet, Michael Zech, Ulrich A Schatz, Robert Jech
Förderung
- Deutsche Forschungsgemeinschaft
- European Joint Programme on Rare Diseases
- German Federal Ministry of Education and Research
- National Institute for Neurological Research, Czech Republic
- European Union-Next Generation EU
- Charles University
- Univerzita Karlova v Praze
Zitieren
APA
Brunet, T., Zech, M., Schatz, U. A., Adamovičová, M., Wagner, M., Graf, E., Berutti, R., Weigand, H., Jech, R., Meitinger, T., Winkelmann, J., & Brugger, M. (2026). De Novo Variants in PPFIA2 in Individuals With Neurodevelopmental Disorders. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64255
Vancouver
Brunet T, Zech M, Schatz UA, Adamovičová M, Wagner M, Graf E, et al. De Novo Variants in PPFIA2 in Individuals With Neurodevelopmental Disorders. American Journal of Medical Genetics Part A. 2026. doi:10.1002/ajmg.a.64255
BibTeX
@article{Brunet2026,
author = {Brunet, Theresa and Zech, Michael and Schatz, Ulrich A and Adamovičová, Miriam and Wagner, Matias and Graf, Elisabeth and Berutti, Riccardo and Weigand, Heike and Jech, Robert and Meitinger, Thomas and Winkelmann, Juliane and Brugger, Melanie},
title = {De Novo Variants in PPFIA2 in Individuals With Neurodevelopmental Disorders},
journal = {American Journal of Medical Genetics Part A},
year = {2026},
doi = {10.1002/ajmg.a.64255}
}
EUVIMED